Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting

European heart journal, 2018-01, Vol.4 (1), p.15-22 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology. 2017 ;The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology. ;COPYRIGHT 2018 Oxford University Press ;info:eu-repo/semantics/openAccess ;ISSN: 2055-6837 ;ISSN: 0195-668X ;EISSN: 2055-6845 ;EISSN: 1522-9645 ;DOI: 10.1093/ehjcvp/pvx010 ;PMID: 28444187

Full text available